Mucolipidosis type IV protein TRPML1-dependent lysosome formation

Traffic

Volumn 16, Issue 3, 2015, Pages 284-297

  Miller, Austin ^a   Schafer, Jessica ^a   Upchurch, Cameron ^a   Spooner, Ellen ^a   Huynh, Julie ^a   Hernandez, Sebastian ^a   Mclaughlin, Brooke ^a   Oden, Liam ^a   Fares, Hanna ^a  

^a The University of Arizona   (United States)

Author keywords

Lysosome; Mucolipidosis type IV; TRPML1

Indexed keywords

CATION CHANNEL; MUCOLIPIDOSIS TYPE 4; PROTEIN; PROTEIN TRPML1; UNCLASSIFIED DRUG; MCOLN1 PROTEIN, MOUSE; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENDOSOME; LYSOSOME; MACROPHAGE; MUCOLIPIDOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; BONE MARROW; CELL LINE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BONE MARROW; CELL LINE; ENDOSOMES; LYSOSOMES; MICE; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84923228346     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12249     Document Type: Article

References (37)

1. Dunn WA Jr. Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol 1994;4:139-143.
2. Luzio JP, Pryor PR, Gray SR, Gratian MJ, Piper RC, Bright NA. Membrane traffic to and from lysosomes. Biochem Soc Symp 2005;72:77-86.
3. Mullins C, Bonifacino JS. The molecular machinery for lysosome biogenesis. Bioessays 2001;23:333-343.
4. Fehrenbacher N, Jaattela M. Lysosomes as targets for cancer therapy. Cancer Res 2005;65:2993-2995.
5. Gyrd-Hansen M, Farkas T, Fehrenbacher N, Bastholm L, Hoyer-Hansen M, Elling F, Wallach D, Flavell R, Kroemer G, Nylandsted J, Jaattela M. Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Mol Cell Biol 2006;26:7880-7891.
6. (2+)-regulated exocytosis of lysosomes. Cell 2001;106:157-169.
7. 2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 1997;137:93-104.
8. Yamashima T, Oikawa S. The role of lysosomal rupture in neuronal death. Prog Neurobiol 2009;89:343-358.
9. Ballabio A, Gieselmann V. Lysosomal disorders: from storage to cellular damage. Biochim Biophys Acta 2009;1793:684-696.
10. Vellodi A. Lysosomal storage disorders. Br J Haematol 2005;128:413-431.
11. Bright NA, Gratian MJ, Luzio JP. Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Curr Biol 2005;15:360-365.
12. Pryor PR, Mullock BM, Bright NA, Gray SR, Luzio JP. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J Cell Biol 2000;149:1053-1062.
13. Puertollano R, Kiselyov K. TRPMLs: in sickness and in health. Am J Physiol Renal Physiol 2009;296:F1245-F1254.
14. Slaugenhaupt SA. The molecular basis of mucolipidosis type IV. Curr Mol Med 2002;2:445-450.
15. Thompson EG, Schaheen L, Dang H, Fares H. Lysosomal trafficking functions of mucolipin-1 in murine macrophages. BMC Cell Biol 2007;8:54.
16. Venugopal B, Browning MF, Curcio-Morelli C, Varro A, Michaud N, Nanthakumar N, Walkley SU, Pickel J, Slaugenhaupt SA. Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am J Hum Genet 2007;81:1070-1083.
17. Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurz T, Xu H. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 2008;455:992-996.
18. Dong XP, Wang X, Shen D, Chen S, Liu M, Wang Y, Mills E, Cheng X, Delling M, Xu H. Activating mutations of the TRPML1 channel revealed by proline-scanning mutagenesis. J Biol Chem 2009;284:32040-32052.
19. Kiselyov K, Chen J, Rbaibi Y, Oberdick D, Tjon-Kon-Sang S, Shcheynikov N, Muallem S, Soyombo A. TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J Biol Chem 2005;280:43218-43223.
20. Pryor PR, Reimann F, Gribble FM, Luzio JP. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic 2006;7:1388-1398.
21. Chen CS, Bach G, Pagano RE. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci USA 1998;95:6373-6378.
22. Rong Y, Liu M, Ma L, Du W, Zhang H, Tian Y, Cao Z, Li Y, Ren H, Zhang C, Li L, Chen S, Xi J, Yu L. Clathrin and phosphatidylinositol-4, 5-bisphosphate regulate autophagic lysosome reformation. Nat Cell Biol 2012;14:924-934.
23. Treusch S, Knuth S, Slaugenhaupt SA, Goldin E, Grant BD, Fares H. Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc Natl Acad Sci USA 2004;101:4483-4488.
24. Grassart A, Cheng AT, Hong SH, Zhang F, Zenzer N, Feng Y, Briner DM, Davis GD, Malkov D, Drubin DG. Actin and dynamin2 dynamics and interplay during clathrin-mediated endocytosis. J Cell Biol 2014;205:721-735.
25. Chun DK, McEwen JM, Burbea M, Kaplan JM. UNC-108/Rab2 regulates postendocytic trafficking in Caenorhabditis elegans. Mol Biol Cell 2008;19:2682-2695.
26. Spooner E, McLaughlin BM, Lepow T, Durns TA, Randall J, Upchurch C, Miller K, Campbell EM, Fares H. Systematic screens for proteins that interact with the Mucolipidosis type IV protein TRPML1. PLoS One 2013;8:e56780.
27. Bargal R, Bach G. Mucolipidosis type IV: abnormal transport of lipids to lysosomes. J Inherit Metab Dis 1997;20:625-632.
28. Eichelsdoerfer JL, Evans JA, Slaugenhaupt SA, Cuajungco MP. Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel. J Biol Chem 2010;285:34304-34308.
29. Jansen SM, Groener JE, Bax W, Poorthuis BJ. Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis. J Inherit Metab Dis 2001;24:577-586.
30. LaPlante JM, Sun M, Falardeau J, Dai D, Brown EM, Slaugenhaupt SA, Vassilev PM. Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol Genet Metab 2006;89:339-448.
31. Lubensky IA, Schiffmann R, Goldin E, Tsokos M. Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia. Am J Surg Pathol 1999;23:1527-1531.
32. Miedel MT, Rbaibi Y, Guerriero CJ, Colletti G, Weixel KM, Weisz OA, Kiselyov K. Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis. J Exp Med 2008;205:1477-1490.
33. Tellez-Nagel I, Rapin I, Iwamoto T, Johnson AB, Norton WT, Nitowsky H. Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch Neurol 1976;33:828-835.
34. Venugopal B, Mesires NT, Kennedy JC, Curcio-Morelli C, Laplante JM, Dice JF, Slaugenhaupt SA. Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol 2009;219:344-353.
35. Vergarajauregui S, Connelly PS, Daniels MP, Puertollano R. Autophagic dysfunction in mucolipidosis type IV patients. Hum Mol Genet 2008;17:2723-2737.
36. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DC. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005;17:393-403.
37. Sambrook J, Fritch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.